CLINICAL_TRIALS
trial_result
· 2023-11-02
Clinical Trial Update: Hereditary Sensory Neuropathy Serine Trial [Phase 2]
Summary
Phase 2 trial update for hereditary sensory neuropathy type I; current status and sponsor information provided, no results yet.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University College, London | Conditions: Hereditary Sensory Neuropathy Type I | Phase 2 | Status: UNKNOWN